Veru EPS VERU

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Veru's earnings per share was −$3.80 over the twelve months to Mar 31, 2024.

In its latest quarter, Q2 FY24, it was −$0.70.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY24	Mar 31, 2024	−$0.70	n/a	−$3.80
Q1 FY24	Dec 31, 2023	−$0.80	n/a	−$7.30
Q4 FY23	Sep 30, 2023	−$0.90	n/a	−$11.30
Q3 FY23	Jun 30, 2023	−$1.40	n/a	−$15.50
Q2 FY23	Mar 31, 2023	−$4.20	n/a	−$16.90
Q1 FY23	Dec 31, 2022	−$4.80	n/a	−$14.50
Q4 FY22	Sep 30, 2022	−$5.10	n/a	−$10.50
Q3 FY22	Jun 30, 2022	−$2.80	n/a	−$5.90
Q2 FY22	Mar 31, 2022	−$1.80	n/a	−$3.40
Q1 FY22	Dec 31, 2021	−$0.80	−135%	−$2.00
Q4 FY21	Sep 30, 2021	−$0.50	n/a	$1.10
Q3 FY21	Jun 30, 2021	−$0.30	n/a	−$0.10

Companies in Drug Manufacturers - General nearest Veru's size, closest first, today.

Company	EPS, 12 months	Growth
VERUVeru	n/m
ATNMActinium Pharmaceuticals	$0.36
SPROSpero Therapeutics	$0.11
LFVNLifevantage	$0.40	−46% a year
NATRNatures Sunshine Products	$1.01	+36% a year
Peer median	$0.38

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.